|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Endocrinology and Metabolism, Department of Internal Medicine, and 2 Department of Clinical Pathology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki 305-8575; 3 Department of Cardiology, Juntendo University, Tokyo 113-8421; and 4 Departments of Physiology and Morphology, Institute of Medical Chemistry, Hoshi University, Tokyo 142-8501, Japan
In this study, using GK
diabetic rats, we compared the effects of three insulin sensitizers on
lipid oxidation and the aortic relaxation response. Eight-week-old rats
were treated for 4 wk with either troglitazone or pioglitazone, both of
which are thiazolidinediones, or with metformin. Despite the fact that
only troglitazone has a similarity in structure to
-tocopherol, a
potent antioxidant, the level of thiobarbituric acid-reactive substance
was lower, and the lag time of the conjugated dienes was longer, in the
blood samples from the rats in both troglitazone- and
pioglitazone-treated groups. In contrast, another insulin sensitizer,
metformin, failed to inhibit the oxidation of blood samples. The aortic
vasorelaxation response was increased in both troglitazone- and
metformin-treated groups compared with the untreated group.
These findings suggest that thiazolidinediones have a beneficial effect
on lipid oxidation irrespective of the drug's structural similarity to
-tocopherol. It is also suggested that the thiazolidinediones and
metformin improve vascular function in diabetes. These effects may play a role in the prevention of atherosclerosis in diabetic patients.
diabetes mellitus; low-density lipoprotein; endothelium; Goto-Kakizaki rats
This article has been cited by other articles:
![]() |
T. Matsumoto, K. Ishida, N. Nakayama, T. Kobayashi, and K. Kamata Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1388 - H1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsumoto, E. Noguchi, K. Ishida, T. Kobayashi, N. Yamada, and K. Kamata Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1165 - H1176. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |